Cargando…

Priming persistence of HCV

Detalles Bibliográficos
Autores principales:	Schuch, Anita, Thimme, Robert, Hofmann, Maike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741531/ https://www.ncbi.nlm.nih.gov/pubmed/26356568

Ejemplares similares

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation
por: Wieland, Dominik, et al.
Publicado: (2017)

The Role of Natural Killer Cells and CD8(+) T Cells in Hepatitis B Virus Infection
por: Schuch, Anita, et al.
Publicado: (2014)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021)

Unique and Common Features of Innate-Like Human Vδ2(+) γδT Cells and Mucosal-Associated Invariant T Cells
por: Provine, Nicholas M., et al.
Publicado: (2018)

Methodologies for the Analysis of HCV-Specific CD4(+) T Cells
por: Lokhande, Megha U., et al.
Publicado: (2015)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Diversity and Evolution of HIV and HCV
por: Martinez, Miguel Angel
Publicado: (2021)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy
por: Heim, Kathrin, et al.
Publicado: (2019)

Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection
por: Oberhardt, Valerie, et al.
Publicado: (2022)

Eliminating HCV: a marathon, not a sprint
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Peripheral B Cells as Reservoirs for Persistent HCV Infection
por: Ito, Masahiko, et al.
Publicado: (2011)

HCV infection treatment: a future full of hope
por: Amiri, Majid, et al.
Publicado: (2013)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017)

Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection
por: Hoare, Matthew, et al.
Publicado: (2008)

Prime time for chronic kidney disease
por: Weisman, David S., et al.
Publicado: (2023)

Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection
por: Sansonno, Domenico
Publicado: (2012)

Responding to HBV and HCV in China and India: thematic series introduction
por: Manciya Mtshali, Phangisile
Publicado: (2016)

Telemedicine and specialised consultations in prisons. The example of HCV chronic hepatitis
por: Fernández Rodríguez, C, et al.
Publicado: (2019)

Memories of Stress: The Imprinted Cancer Risk After HCV Cure
por: Lupberger, Joachim, et al.
Publicado: (2023)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Toward a Better Understanding of Hepatocellular Carcinoma Immune Infiltrates
por: Buettner, Nico, et al.
Publicado: (2019)

Targeting Tumor Stroma: Exploiting Apoptotic Priming
por: Mertens, Joachim C., et al.
Publicado: (2012)

Exercise: A Gate That Primes the Brain to Perform
por: Perrey, Stéphane
Publicado: (2020)

SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
por: Reeg, David B., et al.
Publicado: (2023)

TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes
por: Rizza, Stacey A., et al.
Publicado: (2011)

Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
por: Kim, Hyon-Suk
Publicado: (2009)

Special Issue “Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
por: Liberto, Maria Carla, et al.
Publicado: (2022)

Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma
por: Rennert, Charlotte, et al.
Publicado: (2021)

Bacteria primed by antimicrobial peptides develop tolerance and persist
por: Rodríguez-Rojas, Alexandro, et al.
Publicado: (2021)

Management of Portal/Mesenteric Vein Thrombosis
por: Kalff, Jörg C., et al.
Publicado: (2014)

Noninvasive Electrocardiographic Mapping: Are We Ready for Prime Time?
por: Aryana, Arash, et al.
Publicado: (2015)

Priming Mononuclear Cells to Improve Outcomes of Regenerative Therapy
por: Choksi, Kashyap, et al.
Publicado: (2014)

New Advances in Cardiorenal Syndrome—Ready for Prime Time?
por: Pliquett, Rainer U.
Publicado: (2022)

The prime time for management of hepatocellular carcinoma in Hong Kong
por: Chan, Landon L., et al.
Publicado: (2023)

Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d1v4qlpf2mnf6rvmhmea9c68pq